Moreover, HLA-DQ rs3920 and ICAM-1 rs1437 alleles varied significantly among borderline and malignant types of ovarian cancer, highlighting once more the need for an individual approach to different ovarian cancer subtypes [43]. This evidence concerns the gene ICAM1 and ovarian cancer.